SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial, 2023, Yannaki et al
Discussion in 'Epidemics (including Covid-19, not Long Covid)' started by EndME, Aug 19, 2023.
Tags:
Discussion in 'Epidemics (including Covid-19, not Long Covid)' started by EndME, Aug 19, 2023.